Boston Scientific’s $320 Million Acquisition of Devoro Medical

Faegre Drinker Biddle & Reath advised Boston Scientific on the deal.

Medical device company Boston Scientific announced its acquisition of Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform. Boston Scientific has been a strategic investor in Devoro Medical since 2019 and currently holds an equity stake of approximately 16 percent. Before considering Boston Scientific’s current equity ownership, debt and other closing adjustments, the transaction price consists of $320 million up front, and up to $80 million upon achievement of certain clinical and regulatory milestones. The transaction is anticipated to close in the fourth quarter of 2021, subject to customary closing conditions.

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, the company advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

The Faegre Drinker team was led by corporate partners Matt Stamski (Picture) and Brandon Mason.  It also included corporate associates Vanessa Tabler, Conor White and Sujata Patel Wiese and legal clerk Katharine Thayer; benefits and executive compensation partner Gayle Skolnik and associate Mark Rosenfeld; energy and environment partner Lynn Kornfeld; labor and employment partner Daniel Prokott and associate Kerry C. Zaroogian; intellectual property partners Jason Kraus and Robert Leonard; and privacy, cybersecurity and data strategy partner Doriann Cain.

Involved fees earner: Doriann Cain – Faegre Drinker Biddle & Reath LLP; Lynn Kornfeld – Faegre Drinker Biddle & Reath LLP; Jason Kraus – Faegre Drinker Biddle & Reath LLP; Robert Leonard – Faegre Drinker Biddle & Reath LLP; Brandon Mason – Faegre Drinker Biddle & Reath LLP; Daniel Prokott – Faegre Drinker Biddle & Reath LLP; Mark Rosenfeld – Faegre Drinker Biddle & Reath LLP; Gayle Skolnik – Faegre Drinker Biddle & Reath LLP; Matt Stamski – Faegre Drinker Biddle & Reath LLP; Conor White – Faegre Drinker Biddle & Reath LLP; Sujata Wiese – Faegre Drinker Biddle & Reath LLP; Kerry Zaroogian – Faegre Drinker Biddle & Reath LLP; Vanessa Tabler – Fried Frank Harris Shriver & Jacobson;

Law Firms: Faegre Drinker Biddle & Reath LLP; Fried Frank Harris Shriver & Jacobson;

Clients: Boston Scientific S.p.A.;

Author: Martina Bellini